Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

HL Greenstone, JD Nieland… - Proceedings of the …, 1998 - National Acad Sciences
Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

HL Greenstone, JD Nieland… - Proceedings of the …, 1998 - pubmed.ncbi.nlm.nih.gov
Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

HL Greenstone, JD Nieland, KE de Visser… - Proceedings of the …, 1998 - cir.nii.ac.jp
< jats: p> Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine
candidate to prevent human papillomavirus (HPV) infections and associated epithelial …

Chimeric Papillomavirus Virus-Like Particles Elicit Antitumor Immunity against the E7 Oncoprotein in an HPV16 Tumor Model

HL Greenstone, JD Nieland… - Proceedings of the …, 1998 - ui.adsabs.harvard.edu
Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the e7 oncoprotein in an hpv16 tumor model

HL Greenstone, JD Nieland, KE De Visser… - Proceedings of the …, 1998 - vbn.aau.dk
Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …

[HTML][HTML] Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

HL Greenstone, JD Nieland, KE de Visser… - Proceedings of the …, 1998 - ncbi.nlm.nih.gov
Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.

HL Greenstone, JD Nieland, KE de Visser… - Proceedings of the …, 1998 - europepmc.org
Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …

[PDF][PDF] Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

R KIRNBAUER, RBS RODEN, DR LOWY… - Proc. Natl. Acad. Sci …, 1998 - researchgate.net
Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …

Chimeric Papillomavirus Virus-Like Particles Elicit Antitumor Immunity against the E7 Oncoprotein in an HPV16 Tumor Model

HL Greenstone, JD Nieland, KE De Visser… - Proceedings of the …, 1998 - JSTOR
Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the e7 oncoprotein in an hpv16 tumor model

HL Greenstone, JD Nieland… - Proceedings of the …, 1998 - pure.johnshopkins.edu
Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to
prevent human papillomavirus (HPV) infections and associated epithelial neoplasia …